Masamitsu Nakao

10PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyCardiology (incl. cardiovascular diseases)Sport and exercise nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 28, 2026
Validation of the Baveno Endoscopy Avoidance Criteria in Japanese Patients With Chronic Liver Disease: A Real-World Cohort Study.

|Aug 14, 2026
Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor-Induced Liver Injury.

|May 03, 2025
Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021.

Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida

|May 27, 2023
Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.

Yoshihito Uchida, Yukinori Imai, Shohei Tsuji

|Feb 03, 2022
Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.

Yoshihito Uchida, Hayato Uemura, Shohei Tsuji

|Sep 04, 2020
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.

Yoshihito Uchida, Mie Inao, Shohei Tsuji

Pageof 2

Frequent Collaborators

10 joint publications

Yoshihito Uchida

5 joint publications

Nobuaki Nakayama

2 joint publications

Suguru Mizuno

1 joint publications

Keisuke Kakisaka